GET THE APP

Diagnostic and prognostic value of UHRF1 in breast cancer patients
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Diagnostic and prognostic value of UHRF1 in breast cancer patients


3rd World Congress on Cancer Science & Therapy

October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Feng Yan

Accepted Abstracts: J Cancer Sci Ther

Abstract :

Ubiquitin-like, containing PHD and RING finger domains 1 (UHRF1) has been reported to play an important role in breast carcinogenesis. This work investigated the correlation of UHRF1 DNA level in plasma with clinical characteristics of breast cancer and its clinical significance in breast cancer diagnosis. The expression of UHRF1 in primary breast cancer tissue was examined by western blot. The UHRF1 DNA levels in plasma and UHRF1 mRNA expression in tissues were determined by accurate real-time quantitative PCR. The associations of UHRF1 levels with clinical variables were evaluated using standard statistical methods. The UHRF1 DNA in plasma of 229 breast cancer patients showed higher expression than healthy controls, which showed high specificity up to 76.2% at a sensitivity of 79.2%, and was significantly associated with c-erbB2 positive status, cancer stage and lymph node metastasis. High UHRF1 DNA level in plasma was significantly associated with short progression- free survival. The UHRF1 DNA level in plasma is highly correlative with breast cancer and its status and stage, and may be a potential independent diagnostic and prognostic factor for both breast cancer and the survival of breast cancer patients.

Biography :

Afshin Amini completed his doctoral degree in Medicine in 1997. Being interested in cancer research, he was granted a competitive international postgraduate scholarship by the University of New South Wales (Sydney, Australia) in 2012. As a member of Professor Morris?s research team at St George Hospital, Afshin is currently involved in some key projects aimed to develop novel approaches to cancer therapy.

Google Scholar citation report
Citations: 5282

Cancer Science & Therapy received 5282 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward